According to Zacks, “Corindus Vascular Robotics, Inc. is involved in designing, manufacturing and selling precision vascular robotic-assisted systems for interventional vascular procedures. The Company’s product includes CorPath 200 system a vascular robotic system which provide stent placement in percutaneous coronary intervention procedures. Corindus Vascular Robotics, Inc. is based in Waltham, Massachusetts. “
Separately, Cowen lowered shares of Corindus Vascular Robotics from an outperform rating to a market perform rating and raised their price objective for the company from $4.00 to $4.28 in a report on Thursday, August 8th.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its quarterly earnings results on Thursday, August 8th. The medical equipment provider reported ($0.06) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.01). The business had revenue of $4.58 million for the quarter, compared to the consensus estimate of $4.10 million.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Jane Street Group LLC acquired a new stake in Corindus Vascular Robotics during the 4th quarter worth $36,000. Virtu Financial LLC raised its stake in Corindus Vascular Robotics by 128.4% during the 1st quarter. Virtu Financial LLC now owns 173,312 shares of the medical equipment provider’s stock worth $301,000 after acquiring an additional 97,445 shares in the last quarter. First Republic Investment Management Inc. acquired a new stake in Corindus Vascular Robotics during the 1st quarter worth $122,000. Independent Advisor Alliance acquired a new stake in Corindus Vascular Robotics during the 1st quarter worth $75,000. Finally, EAM Global Investors LLC acquired a new stake in Corindus Vascular Robotics during the 1st quarter worth $1,024,000.
Corindus Vascular Robotics Company Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.
See Also: How Does the Quiet Period Work?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.